Los Angeles
SERVICE FOCUS
Bar Admission
California
New York
Texas
Massachusetts
District of Columbia
U.S. Patent and Trademark Office
Language
English
Mandarin Chinese
Academic
• J.D., Northwestern University Pritzker School of Law
• Ph.D., North Carolina State University
• B.S., University of Science and Technology of China
Andy Yu
Partner
Andy Yu is a Partner at ILS, focusing on high-stakes intellectual property litigation and strategic IP counseling. With a rare combination of legal, scientific, and business expertise, Andy helps technology and life sciences companies protect their innovations, navigate complex disputes, and turn intellectual property into a competitive advantage. His approach goes beyond litigation, aligning legal strategies with his clients' commercial priorities and long-term growth objectives.
Andy represents clients in complex patent disputes before federal courts and the U.S. International Trade Commission (ITC), with experience spanning semiconductors, software, consumer electronics, pharmaceuticals, biotechnology, and medical devices. Beyond the courtroom, he advises on patent portfolio strategy, licensing, IP valuation, and transactions, helping businesses maximize the commercial value of their innovations while managing legal and competitive risks.
Having served as General Counsel to a technology startup, where he helped secure over $30 million in financing, Andy brings firsthand insight into the challenges facing founders, executives, and investors. His background as a principal investigator at Merck and a software developer at SAS Institute further enables him to bridge sophisticated technology, legal strategy, and business decision-making.
Before joining ILS, Andy practiced at leading litigation firms, including Quinn Emanuel and Mintz Levin. He earned his J.D., cum laude, from Northwestern University Pritzker School of Law, and holds a Ph.D. in Bioinformatics and Statistics from North Carolina State University. Combining elite legal training with deep technical expertise and executive-level business experience, Andy delivers commercially focused counsel designed to protect innovation and advance his clients' strategic interests.
Representative Matters
• Represented leading technology and life sciences companies in high-stakes patent litigation before federal district courts and the U.S. International Trade Commission (ITC).
• Represented Google in complex patent litigation involving wireless audio technologies, securing a favorable claim construction ruling.
• Represented Genevant in patent litigation against Pfizer and BioNTech involving lipid nanoparticle technologies used in COVID-19 vaccines.
• Secured an ITC exclusion order on behalf of AMD in a semiconductor patent dispute involving major global electronics manufacturers.
• Represented Netlist in patent disputes against SK Hynix, contributing to a global settlement involving a $40 million licensing payment and a $600 million supply commitment.
• Successfully represented pharmaceutical companies in complex patent litigation, including a 10-day trial resulting in a favorable judgment on all issues.
• Served as General Counsel to a technology startup, leading its intellectual property strategy and helping secure over $30 million in financing.
• Advised Pfizer on the divestiture and $2.2 billion IPO of its animal health business, Zoetis.